Expand ABCL Menu
ABCL MENU

ABCL Stock Posts


ABCL stock declines -4.2% in after hours trading. See the latest news.

After Hours Decliner

ABCL Abcellera Biologics - Common Shares9.76+0.42+4.5%

After Hours:9.35-0.41 (-4.2%)

These Have the Market Hot Zone Catalysts and Setups

Globe NewswireTue, 11-Aug 4:52 PM

ABCL stock declines -5.3% in after hours trading. See the latest news.

After Hours Decliner

ABCL Abcellera Biologics - Common Shares9.76+0.42+4.5%

After Hours:9.25-0.51 (-5.3%)

These Have the Market Hot Zone Catalysts and Setups

Globe NewswireTue, 11-Aug 4:52 PM

Unusual Option Volume

ABCL Abcellera Biologics - Common Shares10.06+0.72 (+7.7%)

Abcellera Biologics - Common Shares trades 6,528 contracts.

ABCL 9.20+2.27 (+32.8%)Abcellera Biologics - Common Shares

  • ATM straddle for 21-Aug-26 expiration returned a positive 120.8% from the previous business day
  • The upside wing (25 delta calls) gained 816.7%
  • Downside put (25 delta puts) lost -85.7%
  • The company has the following event: Investor Conference Call and Live Webcast to Discuss Phase 2 Top-Line Results for ABCL635 on Aug 10, 2026.
  • The option volume for 21-Aug-26 expiration is 13,009
  • News: The Catalysts are Back: Socket Mobile Breaks Out while Biotechs Race Toward Major Milestones
Unusual Option Volume

ABCL Abcellera Biologics - Common Shares8.97+2.04 (+29.4%)

Abcellera Biologics - Common Shares trades 5,088 contracts. The company has the following event: Investor Conference Call and Live Webcast to Discuss Phase 2 Top-Line Results for ABCL635 on Aug 10, 2026. News: AI Found an Influenza Target That Survives Viral Mutation
ABCL stock increases 10.6% after hours.

After Hours Gainer

ABCL Abcellera Biologics - Common Shares6.93+0.40+6.1%

After Hours:7.66+0.73 (+10.6%)

AbCellera to Announce Top-Line Results from the Phase 2 Trial of ABCL635 for the Treatment of Moderate-to-Severe VMS Due to Menopause on Monday, August 10, 2026

Business WireFri, 7-Aug 4:30 PM

Market Data Delayed 15 Minutes